UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 797

Sortiert nach

Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia

Blood, 2013-02, Vol.121 (7), p.1165-1174

2013

Volltextzugriff (PDF)

Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia

Blood, 2012-10, Vol.120 (17), p.3510-3518

2012

Volltextzugriff (PDF)

The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer

Clinical cancer research, 2012-05, Vol.18 (10), p.2780-2790

2012

Volltextzugriff (PDF)

Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall Street

The Journal of immunology (1950), 2015-08, Vol.195 (3), p.755-761

2015

Volltextzugriff (PDF)

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

The New England journal of medicine, 2014-10, Vol.371 (16), p.1507-1517

2014

Volltextzugriff (PDF)

Getting the most from your CAR target

Blood, 2018-10, Vol.132 (14), p.1467-1468

Barrett, David M.

2018

Volltextzugriff (PDF)

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

Nature medicine, 2018-10, Vol.24 (10), p.1499-1503

2018

Volltextzugriff (PDF)

Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial

Journal of clinical oncology, 2021-03, Vol.39 (8), p.920-930

2021

Volltextzugriff (PDF)

Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia

Blood, 2018-03, Vol.131 (9), p.995-999

2018

Volltextzugriff (PDF)

Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy

Blood, 2013-06, Vol.121 (26), p.5154-5157

2013

Volltextzugriff (PDF)

Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy

Blood, 2022-04, Vol.139 (14), p.2173-2185

2022

Volltextzugriff (PDF)

Neurotoxicity after CTL019 in a pediatric and young adult cohort

Annals of neurology, 2018-10, Vol.84 (4), p.537-546

2018

Volltextzugriff (PDF)

Dissecting the Tumor-Immune Landscape in Chimeric Antigen Receptor T-cell Therapy: Key Challenges and Opportunities for a Systems Immunology Approach

Clinical cancer research, 2020-07, Vol.26 (14), p.3505-3513

2020

Volltextzugriff (PDF)

Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell–like blasts in KMT2A-rearranged leukemia

Blood, 2022-04, Vol.139 (14), p.2198-2211

2022

Volltextzugriff (PDF)

Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19

Clinical cancer research, 2022-09, Vol.28 (17), p.3804-3813

2022

Volltextzugriff (PDF)

Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses

Blood, 2009-09, Vol.114 (12), p.2459-2466

2009

Volltextzugriff (PDF)

Eradication of B-ALL using chimeric antigen receptor–expressing T cells targeting the TSLPR oncoprotein

Blood, 2015-07, Vol.126 (5), p.629-639

2015

Volltextzugriff (PDF)

The Beginning of the End of Package Deal Therapy for Patients With High-Risk Neuroblastoma?

Journal of clinical oncology, 2016-07, Vol.34 (21), p.2437-2439

2016

Volltextzugriff (PDF)

Human Adenovirus 7-Associated Hemophagocytic Lymphohistiocytosis-Like Illness: Clinical and Virological Characteristics in a Cluster of Five Pediatric Cases

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e1532-e1538

2021

Volltextzugriff (PDF)

A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor–positive cells

Blood, 2020-02, Vol.135 (7), p.505-509

2020

Volltextzugriff (PDF)

PHOTOSELECTIVE POTASSIUM-TITANYL-PHOSPHATE LASER VAPORIZATION OF THE BENIGN OBSTRUCTIVE PROSTATE: OBSERVATIONS ON LONG-TERM OUTCOMES

The Journal of urology, 2005-10, Vol.174 (4), p.1344-1348

2005

Volltextzugriff (PDF)

Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling

Blood, 2011-10, Vol.118 (15), p.e112-e117

2011

Volltextzugriff (PDF)

1 – 25 von 797

Suche als RSS-Feed

Aktive Filter

KollektionPublisher or Other Site

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(760)
Mit Volltextzugriff
(564)

Publikationsform

Sprache

Englisch
(797)
Japanisch
(131)

Erscheinungsjahr

n.n

Thema

Science & Technology
(527)
Life Sciences & Biomedicine
(466)
Humans
(425)
Male
(229)
Female
(227)
Biological And Medical Sciences
(209)
Medical Sciences
(180)
Adult
(151)
Middle Aged
(140)
Aged
(106)
Animals
(85)
Adolescent
(75)
Child
(68)
Emergency
(54)
General & Internal Medicine
(53)
Medicine, General & Internal
(51)
Risk Factors
(51)
Urology & Nephrology
(50)
Multidisciplinary Sciences
(49)
Science & Technology - Other Topics
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia

Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia

The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer

Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall Street

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

Getting the most from your CAR target

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial

Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia

Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia

Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy

Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells

Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy

Neurotoxicity after CTL019 in a pediatric and young adult cohort

Dissecting the Tumor-Immune Landscape in Chimeric Antigen Receptor T-cell Therapy: Key Challenges and Opportunities for a Systems Immunology Approach

Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell–like blasts in KMT2A-rearranged leukemia

Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19

Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses

Eradication of B-ALL using chimeric antigen receptor–expressing T cells targeting the TSLPR oncoprotein

The Beginning of the End of Package Deal Therapy for Patients With High-Risk Neuroblastoma?

Human Adenovirus 7-Associated Hemophagocytic Lymphohistiocytosis-Like Illness: Clinical and Virological Characteristics in a Cluster of Five Pediatric Cases

A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor–positive cells

PHOTOSELECTIVE POTASSIUM-TITANYL-PHOSPHATE LASER VAPORIZATION OF THE BENIGN OBSTRUCTIVE PROSTATE: OBSERVATIONS ON LONG-TERM OUTCOMES

Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling

Aktive Filter

Suchergebnisse filtern